| Debate around brain enhancement drugs David Pescovitz At O'Reilly's Emerging Technology Conference last week,
I hosted a panel on the future of "mind
hacks," from cognitive fitness programs to smart drugs to neuro-implants.
One of the panelists was Timo Hannay, publishing director of Nature.com,
who talked about a recent heated debate
taking place on the journal's site around the ethics of using brain
drugs for wakefulness, focus, and other cognitive "enhancements."
Nature is continuing that discussion with a public "brain boosting
drugs" survey. Today's New York Times "Week In Review"
takes a look at the controversy. From the New York Times:
|
|||||